Discover
BNGO
Bionano Genomics, Inc.
1.73
20 x 1.12
1 x 1.90
bid
ask
-
0.01
0.57%
11 @ 04:22 AM
1.72 -0.01 (0.58%)
| Ytd | 13.07% | |
| 1y | -3.35% |
1.69
day range
1.87
1.00
52 week range
2.23
| Open | 1.75 | Prev Close | 1.74 | Low | 1.69 | High | 1.87 | Mkt Cap | 20.37M |
| Vol | 1.20M | Avg Vol | 852.69K | EPS | -3.01 | P/E | N/A | Forward P/E | -0.41 |
| Beta | 1.65 | Short Ratio | 3.81 | Inst. Own | 12.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 1.21 | 200-d Avg | 1.27 | 1yr Est | 1.00 |
BNGO News
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Tempest Therapeutics (NASDAQ:TPST) stock increased by 41.6% to $1.07 during Tuesday's a
benzinga.com
Bionano Genomics Stock Surges Tuesday: What's Going On?
Bionano Genomics is surging Tuesday as investors weigh its growth strategy and favorable milestones
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers PDS Biotechnology (NASDAQ:PDSB) shares rose 63.7% to $0.65 during Tuesday's regular ses
benzinga.com
Bionano Genomics Highlights Three New Independently Authored, Peer-Reviewed Publications Showing Cli
Bionano Genomics, Inc. (NASDAQ:BNGO) today highlighted three new independently authored, peer-review
globenewswire.com
Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Ge
Independent research teams at MD Anderson Cancer Center, the University of Oulu, and the Josep Carre
benzinga.com
Bionano Genomics Subsidiary Says MolDX Issues Proposed LCD For Genome-Wide Molecular Methodologies F
Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (NASDAQ:BNGO) that offers